Unilateral nasal allergen challenge leads to bilateral release of prostaglandin D2

Background Multiple mediators including prostaglandin D2 and leukotriene B4 have been shown to increase in nasal secretions during the early response to nasal challenge with antigen.

[1]  R. Naclerio,et al.  Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine. , 1994, American journal of respiratory and critical care medicine.

[2]  S. Holgate,et al.  The contribution of neurogenic reflexes to hypertonic saline-induced bronchoconstriction in asthma. , 1993, The Journal of allergy and clinical immunology.

[3]  M. Kaliner,et al.  Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. , 1993, The Journal of allergy and clinical immunology.

[4]  R. Naclerio,et al.  Comparison of the secretory response of the nasal mucosa to methacholine and histamine. , 1993, Journal of applied physiology.

[5]  P. Howarth,et al.  The effect of BAY u 3405, a thromboxane receptor antagonist, on prostaglandin D2-induced nasal blockage. , 1993, The Journal of allergy and clinical immunology.

[6]  M. Takeyama,et al.  Substance P and Vasoactive Intestinal Peptide in Nasal Secretions and Plasma from Patients with Nasal Allergy , 1993, The Annals of otology, rhinology, and laryngology.

[7]  J. Furkert,et al.  Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. , 1992, The Journal of allergy and clinical immunology.

[8]  R. Naclerio,et al.  Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine. , 1992, The Journal of allergy and clinical immunology.

[9]  J. Lacroix,et al.  Improvement of symptoms of non‐allergic chronic rhinitis by local treatment with capsaicin , 1991, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[10]  M. Kaliner,et al.  The pathophysiology of rhinitis. V. Sources of protein in allergen-induced nasal secretions. , 1991, The Journal of allergy and clinical immunology.

[11]  R. Ekman,et al.  Capsaicin evokes secretion of nasal fluid and depletes substance P and calcitonin gene‐related peptide from the nasal mucosa in the rat , 1989, British journal of pharmacology.

[12]  R. Naclerio,et al.  Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo. , 1989, The Journal of allergy and clinical immunology.

[13]  F. Levi-Schaffer,et al.  Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells activated with peptides. , 1989, International archives of allergy and applied immunology.

[14]  S. Holgate,et al.  Comparative vascular effects of histamine, prostaglandin (PG) D2 and its metabolite 9α, 11β‐PGF2 in human skin , 1988 .

[15]  S. Holgate,et al.  9 alpha,11 beta-prostaglandin F2, a novel metabolite of prostaglandin D2 is a potent contractile agonist of human and guinea pig airways. , 1987, The Journal of clinical investigation.

[16]  R. Naclerio,et al.  Arachidonic acid metabolites during nasal challenge. , 1987, Archives of otolaryngology--head & neck surgery.

[17]  E. Bleecker,et al.  Profiling of prostaglandin biosynthesis in biopsy fragments of human lung carcinomas and normal human lung by capillary gas chromatography-negative ion chemical ionization mass spectrometry. , 1986, Prostaglandins.

[18]  A. Wardlaw,et al.  Allergen‐Induced Release of Sulphidopeptide Leukotrienes (SRS‐A) and LTB4 in Allergic Rhinitis , 1985, Allergy.

[19]  S. Holgate,et al.  Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. , 1984, Journal of immunology.

[20]  E. Goetzl,et al.  Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. , 1984, Science.

[21]  R. Naclerio,et al.  Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. , 1984, The New England journal of medicine.

[22]  C. Metzler,et al.  Effect of flurbiprofen, a cyclooxygenase inhibiting drug, on induced allergic rhinitis. , 1984, The Journal of allergy and clinical immunology.

[23]  S. Peters,et al.  Arachidonic acid metabolism in purified human lung mast cells. , 1984, Journal of immunology.

[24]  D. N. Landon,et al.  Synthesis of leukotriene B4, and prostanoids by human alveolar macrophages: analysis by gas chromatography/mass spectrometry. , 1984, Prostaglandins.

[25]  S. Wasserman.  Mediators of immediate hypersensitivity. , 1983, The Journal of allergy and clinical immunology.

[26]  R. Naclerio,et al.  Mediator release after nasal airway challenge with allergen. , 1983, The American review of respiratory disease.

[27]  J. Oates,et al.  Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. , 1982, Journal of immunology.

[28]  J. Shelhamer,et al.  The Effects of Arachinoids and Leukotrienes on the Release of Mucus from Human Airways , 1982 .

[29]  M. A. Bray,et al.  Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes , 1980, Nature.

[30]  K. Togawa,et al.  Role of the Vidian Nerve in Nasal Allergy , 1979, The Annals of otology, rhinology, and laryngology.

[31]  S. Karim,et al.  Effect of topical prostaglandins on nasal patency in man. , 1978, Prostaglandins.